Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3043% below fair value
$4.81+0.03 (+0.63%)
Close on Nov 18, 2026Market cap $60.26MP/E 12.0Yield 3.85%
Lifevantage operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Lifevantage's operating income for the twelve months ending Jun 30, 2026 was $6.10M, down 50.0% year over year. For fiscal 2026 it was $6.10M, down 50.0% from the year before. Over ten years it grew -7.6% a year on average. The highest annual figure on record is $21.46M in fiscal 2012.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $6.10M | -50.0% |
| FY2025 | Jun 30, 2025 | $12.20M | +181.6% |
| FY2024 | Jun 30, 2024 | $4.33M | +1.7% |
| FY2023 | Jun 30, 2023 | $4.26M | -43.8% |
| FY2022 | Jun 30, 2022 | $7.58M | -57.0% |
| FY2021 | Jun 30, 2021 | $17.62M | +13.9% |
| FY2020 | Jun 30, 2020 | $15.47M | +57.6% |
| FY2019 | Jun 30, 2019 | $9.81M | -4.9% |
| FY2018 | Jun 30, 2018 | $10.32M | +132.0% |
| FY2017 | Jun 30, 2017 | $4.45M | -66.8% |
| FY2016 | Jun 30, 2016 | $13.41M | -3.5% |
| FY2015 | Jun 30, 2015 | $13.90M | -28.5% |
| FY2014 | Jun 30, 2014 | $19.45M | +61.2% |
| FY2013 | Jun 30, 2013 | $12.07M | -43.8% |
| FY2012 | Jun 30, 2012 | $21.46M | +479.6% |
| FY2011 | Jun 30, 2011 | $3.70M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $1.67M | -22.4% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $1.68M | -58.6% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $487.00K | -85.8% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $2.27M | -11.8% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $2.15M | -26.2% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $4.05M | +109.6% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $3.43M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $2.57M | +243.1% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $2.91M | +11.8% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $1.93M | +21.0% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$1.26M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $749.00K | -41.9% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $2.60M | +74.1% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $1.60M | -12.4% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$1.23M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $1.29M | -72.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $1.50M | -77.3% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $1.83M | -12.6% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$358.00K | -106.6% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $4.61M | +31.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $6.58M | +6.0% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $2.09M | -31.2% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $5.45M | +49.5% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $3.50M | +35.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $6.21M | +9.5% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $3.03M | +35.3% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $3.65M | +527.5% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $2.58M | +94.7% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $5.67M | +31.8% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $2.24M | -2.5% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $581.00K | -75.0% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $1.32M | -5.3% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $4.30M | +179.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $2.30M | +930.5% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $2.33M | +232.4% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $1.40M | -29.6% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $1.54M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $223.00K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $700.00K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $1.99M | – |
See a number that looks wrong?